Celebrating 25 Years of Sculptra®: New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation

Contributed by: Business Wire

Logo

Tags

Biotechnology

Pharmaceutical

Health

Surgery

Sculptra

More Like This

Galderma Celebrates 25 Years of Excellence in Biostimulation With Sculptra® at the 2024 IMCAS

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

Merz Aesthetics Presents New Data in the Field of Regenerative Aesthetics at the 2024 IMCAS World Congress

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Galderma Granted Key Manufacturing License Updates for New Biologics Capabilities at Its Center of Excellence

Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends

IBSA Derma presents the new frontier of adipose tissue restoration in response to aging (Photo: Business Wire)

From the surface to the deep structure of the face: IBSA Derma presents the new frontier of adipose tissue restoration in response to aging